ArticleThe Lancet. Oncology2020
Ivosidenib for advanced IDH1-mutant cholangiocarcinoma - Authors' reply.
Ghassan K Abou-Alfa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe Lancet. Oncology2020
Ghassan K Abou-Alfa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.